View on market: Stay Cautious, be with quality business:

Stocks in Asia were poised to decline Thursday after US shares fell and the treasuries rallied. Shares edged lower in Australia and a gauge of US-listed Chinese companies slumped 2.5%. At 5:51 a.m., the Singapore-traded SGX Nifty, an early indicator of India’s benchmark Nifty 50, was down 0.45% to 18,139.5. U.S. stocks extended losses as economic data sparked concerns over growth outlook. The S&P 500 closed Wednesday 1.6% lower, the biggest decline in a month. The yield on 10-year Treasuries declined to 3.37%. Crude price rose declined by nearly a percent. Bitcoin broke its rally to fall below $21,000-level. Indian benchmark indices maintained their upward trend for the second day in a row, with the Sensex reclaiming the 61,000-mark. Rupee snapped its two-day downfall against the U.S. dollar to close at its highest level since Dec. 2, 2022.

Economic Calendar:

  • USD : Initial Jobless Claims on 19th January, 2023
  • USD : Existing Home Sales (Dec) on 20th January, 2023
  • INR : Infrastructure Output (YoY) (Dec) on 31st January, 2023

Q3FY23 Results Today: Hindustan Unilever, Asian Paints, AU Small Finance Bank, Can Fin Homes, L&T Technology Services, Happiest Minds Technologies, Havells India, Hindustan Zinc, Anant Raj, IIFL Wealth Management, IndiaMART InterMESH, ICICI Securities, Mphasis, Polycab India, PVR, Sterling and Wilson Renewable Energy

Brokerage Radar:

UBS ON TITAN: Downgrade to Neutral, TP cut to Rs 2600; However, in long term, expect Titan’s jewellery segment growth to remain strong; Already trading at 56x FY24E earnings as consensus is factoring 17% CAGR rev growth, therefore, don’t see any further upside potential for stk

MS ON INDUSIND BK: OW, TP Raised to Rs 1525; Both core PPoP (+25% YoY, 5% above MSe) & credit costs (at 160bps; 6bps below MSe) surprised +vely; -Ves were further moderation in SA ratio (partly cyclical) & slower MFI growth pickup

MACQUARIE ON SUN PHARMA: O-p, TP Rs 1275; For Dec’22, Ilumya unit sales in US were down 6% MoM but up 29% YoY; Cequa market share continues to inch up in dry eye market, with 4.6% market share in Dec’22 vs 3.8% in Mar’22; Winlevi TRx growth accelerated, seeing 8% MoM growth

International Markets:

U.S & Europe

Particulars 18th January Chg. Chg.(%)
Nasdaq 10957.01 -138.10 -1.24
Dow 33296.96 -613.89 -1.81
FTSE 7830.70 -20.33 -0.26
CAC 7083.39 6.23 0.09
DAX 15181.80 -5.27 -0.03
Dow Fut.* 33245.50 -51.50 -0.15

Asian markets

Particulars 19th January Chg. Chg.(%)
SGX Nifty 18135.50 -86.50 -0.47
Nikkei 26468.62 -322.50 -1.22
Straits Times 3282.05 -7.50 -0.23
Hang Seng 21598.67 -79.33 -0.37
Shanghai 3222.24 -2.17 -0.07

ADR Watch:

Particulars 18th January  Chg.       Chg.(%)
Dr. Reddy 54.01 0.22 0.41
HDFC Bank 68.65 1.65 2.46
ICICI Bank 21.23 0.13 0.62
Infosys 18.75 0.08 0.43
Tata Motor 24.40 -0.39 -1.57
Wipro 4.97 0.08 1.64

Commodities & Currency

Particulars Current Price Chg.(%)
USD/INR 81.24 -0.66
Brent 84.12 -1.01
Gold 1909.60 0.14
Silver 23.517 -0.55

FIIs & DIIs:

Particulars 18th January 17th January
FIIs                           -319.23 211.06
DIIs 1225.96 90.81

News Update:

Adani Enterprises: The company filed the RHP for its Rs 20,000-crore follow-on public offering, with floor price at Rs 3,112 apiece and cap price at Rs 3,276 per share. The company also announced a discount of Rs 64 per share for retail buyers. Vedanta: The company will acquire the debt-laden Meenakshi Energy for Rs 1,440 crore.

State Bank of India: The bank raised Rs 9,718 crore through 15-year infrastructure bonds at 7.7% coupon rate.

Aurobindo Pharma: The company’s subsidiary APL Health Care received Form 483 with two observations from U.S. FDA following an inspection of its unit I and III, an orals and derma manufacturing facility in Jadcherla, Telangana.

Coal India: In a coal ministry review, the company was found to have produced 513 million tonnes of coal so far in fiscal 2023, and is expected to surpass the target of 700 million tonnes for the current fiscal. The ministry has pegged the production target for the company during 2023-24 at 780 million tonnes.

Kotak Mahindra Bank: The board in its meeting scheduled on Jan. 21 will consider raising funds via non-convertible debentures during the remaining period of FY 2022-23, and by the way of NCDs, bonds or other debt securities during FY24.

Welspun Enterprises: The board of the company has approved voluntary liquidation of subsidiary Welspun Natural Resources to streamline the structure and reduce administrative overheads of the group.

Mahindra Lifespaces Developers: The company has been selected to redevelop two adjacent residential societies in Santacruz West, Mumbai. The project has a revenue potential of Rs 500 crore.

Wipro: The company opened Wipro-AWS Launch Pad Center in Toronto, Canada.

 Source: Moneycontrol, Bloomberg Quint, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited,
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting, or emailing with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website:
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL